Find the latest news about Inaphaea BioLabs here
Life science professionals are invited to gain insights from thought leaders in the industry, network, and enjoy a tour of the facilities at Inaphaea BioLabs at its official launch event supported by…
Inaphaea BioLabs has entered into a collaborative services agreement with Agility Life Sciences to provide a single point of contact for customers to formulate and test their drug candidates. The agreement recognises…
We are delighted to welcome Dr Gareth Griffiths to Inaphaea BioLabs as Scientific Consultant in our Scientific Advisory Support team. Gareth holds a PhD in Immunology and Oncology from the University of…
Earlier this year, our parent company ValiRx announced the launch of Inaphaea BioLabs – a subsidiary company offering a wide range of pre-clinical and drug discovery testing services to academic, biotech, and…
This roundup covers our news, updates, and highlights from July. It has been a particularly busy time for Inaphaea, and we’re looking forward to the lab’s official launch event with BioNow on…
Inaphaea has signed a Master Services Agreement and Project Statement of Work with a UK based biotech company. The first invoice has been issued relating to the work, with subsequent invoices anticipated…
In our new monthly news roundups, we will be sharing our news, updates, and highlights from the past few weeks.
In the third instalment of our ‘meet the team’ series for Inaphaea BioLabs, we discover a little more about Dominic Lowen.
In the second instalment of our ‘meet the team’ series for Inaphaea BioLabs, we discover a little more about Melissa Barr.
Inaphaea BioLabs has entered into an agreement with virtual CRO services company, OncoBone Limited.